Clinical Trials Logo

Clinical Trial Summary

This research study is testing a new way to look for the early stages of anaphylaxis. Eligible participants will have a small monitor (transepidermal water loss) placed on the forearm during a food challenge (for peanut allergies). This monitor continuously records the amount of water lost through the skin. In a previous study the team learned what values are associated with an anaphylactic reaction. These values are called "stopping rules." This study is looking at whether it can use these new stopping rules to end the oral food challenge before a person may show any symptoms.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05696236
Study type Interventional
Source University of Michigan
Contact Christopher Launius
Phone 734-936-5634
Email cmlauniu@umich.edu
Status Recruiting
Phase N/A
Start date May 23, 2023
Completion date March 2027

See also
  Status Clinical Trial Phase
Completed NCT03487315 - Major Allergen in Wheat Anaphylaxis in Thai Population N/A
Completed NCT03149315 - Inhibition of Anaphylaxis by Ibrutinib Phase 2